Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Harmony Healthcare IT Launches Medical Record Consumer Access Solution


“We’ve developed a secure means to integrate historical EHI into the EHR or patient portal so it can be included in the release of information,” said Dave Navarro, Senior Director of Data Science at Harmony Healthcare IT.

Harmony Healthcare IT (Harmony), a leading data management firm, released a new HealthData Integrator™ offering, Secure Record Delivery, to help U.S. healthcare providers comply with the 21st Century Cures Act (Cures Act). The solution enables the transmission of an archived patient record from Harmony’s HealthData Platform™ to an electronic health record (EHR) endpoint.

This interoperability advancement supports best practices in health data exchange, providing consumer access to historical patient records as regulations and penalties around the Information Blocking provisions of the Cures Act expand. Historical medical records are made accessible to patients in a familiar manner so the facility may meet an exception to the Information Blocking provision of the Cures Act [45 CFR 171.103].

“As part of the Cures Act’s call for greater interoperability, healthcare providers may not ‘knowingly or unreasonably interfere’ with the exchange of electronic health information (EHI),” said Dave Navarro, Senior Director of Data Science at Harmony Healthcare IT. “As archived patient records are EHI, they should be included with active EHR records when a consumer request is fulfilled. We’ve developed a secure means by which to integrate that historical EHI into the EHR or patient portal so it can be included in the release of information.”

Secure Record Delivery is made available through HealthData Integrator™, the data activation component on Harmony Healthcare IT’s market-leading HealthData Platform™. HealthData Platform™ is an enterprise-wide, cloud-hosted infrastructure that secures patient, employee, and business records for healthcare delivery organizations.

Secure Record Delivery enables HealthData Platform™ users to navigate the Information Blocking Provision of the Cures Act and better serve patients. The solution is aligned with current and anticipated future designated record set requirements for the information that must be provided for patient record requests to remain compliant with the provision.

To date, there are two phases for the Information Blocking timeline:

· Phase 1, which has been active since April 2021, states that EHI is limited to data defined by the United States Data for Core Interoperability V1 (USCDI V1). The data included in USCDI is a content standard that is a baseline of health data elements such as demographics, problems, allergies, medications, and clinical notes.

· Phase 2 began Oct. 6, 2022, and includes a broader set of “all patient EHI” which has organizations reviewing their definition of a HIPAA designated record set. The Harmony Healthcare IT solution is aligned with current and future versions of the USCDI.

Implementation of Secure Record Delivery by Harmony Healthcare IT’s clients include the following benefits:

· Satisfies the Information Blocking Provision of the 21st Century Cures Act by allowing the delivery of an archived medical record to an active EHR endpoint or patient portal for consumer access

· Securely integrates with industry-leading EHRs with the use of application programming interfaces (APIs) and other encryption methods (See listing on Epic’s Connection Hub)

· Increases patient satisfaction by allowing electronic delivery of a more complete historical record upon request

For more information about HealthData Integrator™ Secure Record Delivery and its impact on historical patient record request fulfillment in relation to the 21st Century Cures Act, listen to this HealthData Talks podcast episode with guest Dave Navarro, Senior Director of Data Science at Harmony Healthcare IT.

About Harmony Healthcare IT

Harmony Healthcare IT is a data management firm that moves, stores, and releases patient, employee, and business records for healthcare organizations. To strengthen care delivery and improve lives, vital information is preserved and managed in a way that keeps it accessible, usable, interoperable, secure, and compliant. Since 2006, its US-based team of experts has worked with over 550 unique clinical, financial, and administrative software brands used in healthcare delivery organizations. Harmony Healthcare IT has been consistently ranked as the #1 data extraction, migration, and archival healthcare IT company according to Black Book™ Market Research for four years (2019-2022) as well as ranked #1 in the 2020 Best in KLAS Software & Services Report as a Category Leader in Data Archiving.

For more information about Harmony Healthcare IT, visit: http://harmonyhit.com.

Share article on social media or email:

Catalent Experts to Co-Host Workshops on Supply Chain Management at Upcoming Global Clinical Supplies Group Conference


Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that two of its clinical supply experts are to co-host workshop sessions at the upcoming Global Clinical Supplies Group (GCSG) Conference, to be held at the Hyatt Regency Grand Cypress Hotel, Orlando, Florida, on April 23 – 26, 2023.

The first workshop, entitled “Autologous Supply Chains,” will be held on Tuesday, April 25 at 11:15 a.m. EDT, and will look at strategies to consider when setting up a patient-centric supply chain for autologous cell therapies, and how to identify resources early in the process that can support chain of identity and chain of custody. Hosting the session will be Trish Demko, Catalent’s Director of Case Management Services, alongside Beth Gardner, Senior Director of Patient Supply at Beam Therapeutics.

Additionally, Amber Brown, Catalent’s Director of Transportation Services, will be co-hosting a workshop, entitled “VAT Regulation and Rebate Options for Clinical Materials” with Melissa Brod from VAT IT. The session will look at ways for clinical trial sponsors to maximize the ability to reclaim value added tax, and will run twice at the conference: on Monday, April 24 at 11:30 a.m. EDT; and again on Tuesday, April 25 at 11:15 a.m. EDT.

In her role at Catalent, Ms. Demko oversees the company’s Case Management Services, launched in January 2023 to address the unique challenges associated with the safe and timely delivery of advanced therapies to patients by providing professional supply chain oversight from program start to finish. She has over 15 years of experience in case management, facilitating bone marrow and stem cell transplant coordination across a global network, overseeing team productivity, quality, and maintaining excellence in customer service. She holds a Bachelor of Science in Biology and a Master of Business Administration degree from Augsburg University, Minneapolis, as well as having Lean Six Sigma Green Belt certification.

Mrs. Brown is responsible for Catalent’s Global Transportation Services, where she supervises courier and shipment management, strategic ‘lean’ value chain optimization, and oversees the economics of the company’s global network against key performance targets. Her experience spans two decades of successfully managing global supply chains across a range of industries, and she holds a bachelor’s degree in business administration and supply chain from Fort Hays State University, Kansas.

To find out more information about this event, visit http://www.catalent.com/events/gcsg-2023-us-conference/

About Catalent Clinical Supply Services

Catalent solves today’s clinical trial challenges and develops innovative solutions for the future. The company’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience of reliably supplying thousands of studies of all sizes and complexities, all around the world.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

SandboxAQ Receives FedHealthIT Disruptive Tech Award for Helping U.S. Department of Health & Human Services Assess Quantum Cyber Threats


Yesterday at the FedHealthIT Disruptive Tech Summit, SandboxAQ received the FedHealthIT Disruptive Tech Award, recognizing SandboxAQ’s Security Suite. The cryptographic management software is currently deployed at the U.S. Department of Health and Human Services.

SandboxAQ recently delivered the first post-quantum cryptography (PQC) inventory in the federal health IT community to HHS–three months ahead of the scheduled delivery date, in partnership with Cart.com. SandboxAQ performed network cryptography analysis and assessed the cybersecurity architecture of Cart.com’s HHS fulfillment network. SandboxAQ also implemented PQC discovery tools to plan for the protection of systems and sensitive data.

The FedHealthIT Disruptive Tech Awards recognize programs from both industry and government that drive transformational progress in the federal market and have a measurable impact on culture and mission.

“Forward-looking agencies realize the tremendous importance of beginning the lengthy PQC migration process immediately,” said Jen Sovada, President, Public Sector at SandboxAQ. “This effort demonstrates the art of the possibility for efficient PQC migration across the U.S. government. SandboxAQ is particularly excited about our partnership with Cart.com, as it showcases our technologies’ dual-use application to help businesses and governments achieve mission success.”

About SandboxAQ

SandboxAQ is an enterprise SaaS company, providing solutions at the nexus of AI and Quantum technology (AQ) to address some of the world’s most challenging problems. The company’s core team and inspiration formed at Alphabet Inc., emerging as an independent, growth-capital-backed company in 2022. For more information, visit http://www.sandboxaq.com.

Share article on social media or email:

Baptist Health Expands Precision Medicine Effort With ActX


Over the past several years ActX has helped Baptist Health make the best therapeutic choices for many patients by personalizing their medical care with genetics

As part of an ongoing effort to expand precision medicine access to their patients and employees, Baptist Health has extended its partnership with its Genomic Decision Support vendor, ActX, until 2028.

At Baptist Health, ActX is integrated into the EpicCare electronic health record, providing actionable genomic decision support at the point of care, allowing Baptist Health providers to make better decisions about medical treatment using patient’s genetic information. Baptist has utilized the service at its nine owned hospitals and more than 400 points of care over the past several years.

In 2022 Baptist Health launched a pilot program to study the benefits of genetic testing with a sample group of its employees. Comparing 2022 claims data to 2020 and 2021, the results showed fewer claims and an average cost savings of $482 per study patient per month, for a total savings of $2.6 million so far. In 2023, Baptist Health included coverage for pharmacogenetic testing to all employees and dependents enrolled in their medical plan.

“Over the past several years ActX has helped Baptist Health make the best therapeutic choices for many patients by personalizing their medical care with genetics” said Brett Oliver, MD, Chief Medical Information Officer at Baptist Health.

“With the extension of the Baptist Health-ActX partnership, we will be able to further expand this important initiative, increasing our capabilities by enabling precision medicine for many more individuals”.

“We are excited to help expand the important work Baptist Health is doing with precision medicine.” said Andrew Ury, MD, CEO of ActX. “Baptist Health has been a leader in showing the important benefits of an EHR integrated genomic decision support model”.

About ActX

ActX helps physicians make better decisions about medical treatment, using patients’ genetic information. ActX uses its GenoACT℠ clinical decision support program to analyze a patient’s genetic information and alert physicians in real time through their existing workflow tools about drug-genome interactions, actionable hereditary risks and carrier status. For more information, visit http://www.actx.com, email info@actx.com or call 888-998-2289.

About Baptist Health

Founded in 1924 in Louisville, Kentucky, Baptist Health is a full-spectrum health system dedicated to improving the health of the communities it serves. The Baptist Health family consists of nine hospitals, employed and independent physicians, and more than 400 points of care, including outpatient facilities, physician practices and services, urgent care clinics, outpatient diagnostic and surgery centers, home care, fitness centers, and occupational medicine and physical therapy clinics.

Baptist Health’s eight owned hospitals include more than 2,300 licensed beds in Corbin, Elizabethtown, LaGrange, Lexington, Louisville, Paducah, Richmond and New Albany, Indiana. Baptist Health also operates the 410-bed Baptist Health Deaconess Madisonville in Madisonville, Kentucky in a joint venture with Deaconess Health System based in Evansville, Indiana. Baptist Health employs more than 23,000 people in Kentucky and surrounding states.

Baptist Health is the first health system in the U.S. to have all of its hospitals recognized by the American Nursing Credentialing Center with either a Magnet® or Pathway to Excellence® designation for nursing excellence.

Baptist Health’s employed provider network, Baptist Health Medical Group, has nearly 1,500 providers, including more than 750 physicians and more than 740 advanced practice clinicians. Baptist Health’s physician network also includes more than 2,000 independent physicians.

Share article on social media or email:

Bola AI Announces Voice Perio Integrations with Open Dental and Dentrix Enterprise


News Image

Our new offerings with Dentrix Enterprise and Open Dental are consistent with our vision to provide voice-enabled periodontal charting to everyone, regardless of which EHR system they use.

Bola Technologies, Inc. (Bola AI), a leading provider of voice-AI technology for healthcare and dental professionals, continues to expand the availability of its revolutionary Voice Perio system to more dental practices throughout North America. The latest integrations available with Bola AI’s innovative technology include Dentrix Enterprise and Open Dental.

Bola AI’s Voice Perio system enables dental staff to seamlessly record periodontal data directly into client PMS and EHR systems in real time. It lessens the burden on dentists, hygienists and front-office staff while simultaneously streamlining clinical documentation and administrative duties, including charting, scheduling, imaging, billing, payment processing and much more.

“Our new offerings with Dentrix Enterprise and Open Dental are consistent with our vision to provide voice-enabled periodontal charting to everyone, regardless of which EHR system they use,” said Rushi Ganmukhi, CEO and founder of Bola AI. “Dental practices have asked for this, and customers have been petitioning for greater overall availability of our Voice Perio software. We are pleased to meet the demand by continuing to roll out the availability of our true touchless charting solution to an ever-expanding customer base.”

Open Dental is an open-source dental practice management software provider based out of Oregon.

In recent years, AI and deep learning have made incredible strides, with computer vision, language processing and speech recognition achieving near-human levels. Bola AI’s Voice Perio delivers speech accuracy at 99% and allows for variable accents and flexible phrasing while filtering out background noise and nonclinical speech. One of the things customers appreciate most is how quickly Bola’s voice-charting software responds, with no lagging evident or voice conditioning needed. The system is typically operational on each customer’s platform within 20 minutes. Bola AI offers the first clinical voice assistant for the dental market to utilize this new age of technology while providing unprecedented ease of use and accuracy.

“At Bola AI, our mission is to provide a truly touchless environment that drives efficiency and revenue for dental practices,” said Ganmukhi. “We’re finding that dental practices across the country are ready to embrace the hands-free charting experience our technology offers.”

Bring innovation and cutting-edge AI technology to your dental practice by partnering with Bola AI today.

About Bola AI

With Bola AI, the future of speech artificial intelligence (AI) is here. By harnessing the power of advanced technologies, this platform can provide efficient, fully integrated and accurate speech (99.9%) solutions for periodontal charting, clinical notes and more. With Bola AI, practices can empower themselves to create a smarter patient experience while improving operational efficiency and driving revenue. Partnering with Dentrix, Ascend, Curve, Patterson, Overjet and more, Bola is the leader in the voice-charting and notes space. Bola AI is headquartered in Boston, MA. For more information, visit bola.ai.

Share article on social media or email:

CREO Unveils New Brand Marketing Campaign; Emphasizes Intrinsic Value CREO Brings to Life Sciences and Healthcare Clients


CREO, the preferred consultancy to the world’s most promising life sciences and healthcare companies, today announced that it is launching a new brand marketing campaign entitled “Potential. Unleashed.”

The campaign launched April 1, 2023 in the digital version of The Triangle Business Journal’s health vertical section. The campaign will also appear online in select national industry trade media later this year and across CREO’s social media marketing.

“The theme of unleashing potential is an important part of CREO’s DNA,” said Susan Acker-Walsh, CEO and co-founder, CREO Inc. “It amplifies the intrinsic value CREO provides to its life sciences and healthcare clients focused on driving innovation to improve human health around the world.”

Since its founding in 2015, CREO has consistently realized significant demand for its services and, as a result, is generating strong momentum and recognition among life sciences, healthcare, and private equity portfolio companies:


  • Over 200% revenue growth rate for last three-year period
  • New senior staff appointments from the life sciences and healthcare industries, including a Chief Strategy Officer and a Director for Strategy & Organizational Effectiveness
  • Services expansion into industry-specific growth opportunities such as Bioanalytical & Clinical Lab Modernization
  • Double-digit annual increase in talent recruitment
  • INC. 5000 Fastest-Growing Company (2020, 2021, 2022)
  • INC. Regionals Mid-Atlantic Fastest-Growing Company (2022, 2023)
  • Triangle Business Journal “Fast 50” Winner (2021, 2022)

“Potential. Unleashed. captures the essence of what CREO is committed to doing with its clients who are researching and delivering tomorrow’s precision therapies and innovations,” said Mike Townley, President and co-founder, CREO Inc. “It reflects our deep commitment to core values like putting people first and creating impact that guide how we work each day.”

About CREO

CREO, Inc. is the preferred consultancy to the world’s most promising companies that seek to improve human health. We serve growing life sciences, healthcare, and private equity portfolio companies. Our expertise and knowledge in Strategy, M&A, Digital Transformation, Cybersecurity, and IT Quality & Regulatory Compliance help organizations improve today’s business performance and develop tomorrow’s clinical innovations. Founded in 2015, CREO is headquartered in North Carolina’s Research Triangle Park. Join us and together let’s make a meaningful difference. Visit CREO at http://www.creoinc.net.

Share article on social media or email:

Seniors Housing and Care M&A Activity Falls Under 100 Deals in Q1:23


News Image

“As lending issues plague the senior care industry and some major loan defaults are potentially around the corner, deal activity and values will take a hit. However, we will likely see all-cash buyers make opportunistic acquisitions throughout the year.”

The number of publicly announced seniors housing and care acquisitions in the first quarter of 2023 fell to 98 deals, based on new acquisition data from LevinPro LTC. This represents a 13% decrease from the 112 transactions disclosed in the fourth quarter of 2022 and a 33% decline from the 144 deals in Q1:22. In addition, the $1.35 billion spent on Q1:23 transactions fell by 31% from the $1.97 billion spent on Q4:22 transactions and by 73% from the $5.07 billion spent in the year-ago first quarter, based on disclosed prices.

“Buyers have taken a big step back from acquisitions in light of spiking capital costs and liquidity issues in the debt markets,” stated Ben Swett, Editor of The SeniorCare Investor. “Deals are a lot harder to get done, and most that close feature value-add assets that trade at low per-unit prices.”

The 98 transactions recorded in Q1:23 represent the lowest quarterly deal total since the first quarter of 2021, when 85 deals were publicly announced, and shows the impact of high interest rates on the M&A market. There were just under 280 properties involved in Q1:23’s deals for a property-per-deal ratio of 2.9, very close to the 2.7 property-per-deal rate from Q4:22. Assisted living deals made up the plurality of Q1:23 deals, accounting for 42%, followed by skilled nursing at 32%. Active adult deals made up 9% of the quarter’s total, independent living took a 7% share, and affordable senior apartments and CCRCs accounted for 6% and 4% of deals, respectively.

There were nine transactions with more than 10 properties in each, and 21 total deals with three or more properties, split roughly even between skilled nursing and seniors housing transactions. Looking at monthly M&A activity, dealmaking dropped in February and March to 28 and 30 transactions, respectively. That is down from 40 deals in January 2023 and the 44-deals-per-month average of 2022.

“As lending issues plague the senior care industry and some major loan defaults are potentially around the corner, deal activity and values will take a hit,” added Swett. “However, we will likely see all-cash buyers make opportunistic acquisitions throughout the year.”

All long-term care M&A deals dating back to 1993 can be accessed on the LevinPro database and can be purchased via a site license. All quarterly results are published in The Health Care M&A Report for all 13 sectors of health care, which is part of LevinPro HC. In addition, annual results of the seniors housing and care acquisition markets will be published this year in the 28th Edition of The Senior Care Acquisition Report. For information, or to subscribe, call 800-248-1668. Irving Levin Associates was established in 1948 and has offices in New Canaan, Connecticut, and North Bethesda, Maryland. The company publishes research reports and newsletters, and maintains databases on the healthcare and seniors housing M&A markets.

Share article on social media or email:

Artificial Intelligence Models in Gastrointestinal Diseases, Upcoming Webinar Hosted by Xtalks


As digital pathology becomes routinely available in anatomic pathology, artificial intelligence (AI)-based technologies have the potential to enhance diagnostic accuracy and speed, histologic feature recognition and various forms of quantitative image analysis of human diseases.

In this webinar, the featured speaker discusses how to develop AI models — using a cloud-based deep learning platform, Aiforia, — that identify and quantify various histologic features in neoplastic, inflammatory and metabolic diseases of the gastrointestinal tract and liver.

Join this webinar on digital pathology to learn how non-AI specialists can develop clinically useful AI-based image analysis models.

Join Dr. Roger K. Moreira, MD, Consultant, Assistant Professor, Mayo Clinic, Rochester, MN, for the live webinar on Wednesday, May 3, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Digital Pathology: Artificial Intelligence Models in Gastrointestinal Disease s.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Clinician Webinar Series Offers Support, Coping Methods During Stress Awareness Month


As April marks Stress Awareness Month, Ingenovis Health’s (Ingenovis) ACT Webinar Series for Healthcare Professionals will focus on coping methods attained through lived experiences, with special guest Shannon McPeek, B.S.N., R.N., owner of Operation Happy Nurse. This free monthly event is part of Ingenovis’ ACT (Advocacy. Career. Tools.) program.

What: The Story of the Stressed-Out Nurse webinar will highlight the challenges of nursing, practices to overcome stress and coping mechanisms to navigate challenges. It will also explore the support system offered through the non-profit, Operation Happy Nurse.

When: Thursday, April 20 at 2:30 p.m. EST

Participants: Webinar host – Dr. Robin Geiger, Ingenovis Senior Vice President of Clinician Advocacy

Guest speaker – Shannon McPeek, B.S.N., R.N., Owner, Operation Happy Nurse

Where: Attendees can register for the free Zoom event here.

Why: The ACT program serves as an integral part of Ingenovis’ overall purpose to build a home for healthcare talent across its seven category-leading brands. Created from insights collected from frontline workers, it serves to offer the essential tools and inspirational resources healthcare providers need to grow, flourish and advance in their careers, to help stem the tide of provider attrition. Learn more at ingenovishealth.com.

The information in this webinar series is general, subject to change, should not be construed as professional advice from any of the hosts, presenters or sponsors, and is provided for informational purposes only.

To learn more about Ingenovis Health, visit ingenovishealth.com

About Ingenovis Health

Ingenovis Health is an ingenious new force in healthcare, combining the power of industry-leading workforce solutions providers and a technology-forward approach to advance the delivery of critical healthcare clinicians to systems nationwide. Brands in the portfolio include Trustaff Travel Nurses, Fastaff Travel Nursing, HealthCare Support, U.S. Nursing Corporation, VISTA Staffing Solutions, Springboard Healthcare and CardioSolution. For more information, visit ingenovishealth.com.

Share article on social media or email:

Workers’ Comp Leaders from ODG and The Hartford to Present at IAIABC Forum


ODG by MCG

ODG by MCG is the healthcare industry leader in evidence-based, decision support for workers’ compensation, disability, and auto liability claims management.

“Dr. LaCroix and I are excited to share insights from the years of workers’ compensation claims data with IAIABC attendees.” – Pam Bloom-Pugliese, Director of Product Management, ODG by MCG

ODG by MCG, an MCG Health company and part of the Hearst Health network, announces its Director of Product Management, Pam Bloom-Pugliese, will co-present with Dr. Michael LaCroix, Medical Director of The Hartford Financial Services Group, at the IAIABC Forum happening on April 24-27, 2023 in Clearwater, Florida. This annual forum brings together IAIABC’s committees and councils to discuss policy and administrative issues in workers’ compensation.

Mrs. Bloom-Pugliese and Dr. LaCroix will present the session, “Work Disability Prevention and Return to Work Committee Meeting,” on Wednesday, April 26, 2023, from 9:45 a.m. to 12:15 p.m. (ET). This presentation will address mental health conditions and how they can affect other medical comorbidities, including work-related diagnoses and disability. By evaluating years of claims data, the presenters will explore the financial impact of mental health conditions on workers’ compensation and group benefits claim durations with respect to age, gender, and diagnoses.

“While a great deal of scientific information about mental health is available, specific information about mental health from a claims perspective is limited,” said Mrs. Bloom-Pugliese. “Dr. LaCroix and I are excited to share insights from the years of workers’ compensation claims data with IAIABC attendees. We believe the information in this session will help professionals make recommendations for better management of such claims.”

For those interested in attending the IAIABC Forum 2023, registration details and additional information can be found at: https://www.iaiabc.org/forum-2023.

###

About ODG

ODG, an MCG Health company, (http://www.mcg.com/odg) provides unbiased, evidence-based guidelines that support payers, providers, employers, and auto insurers in their efforts to return people confidently and effectively to health. The clinical guidelines and analytical tools within ODG are designed to improve and benchmark return-to-work performance, facilitate quality care while limiting inappropriate utilization, assess claim risk for interventional triage, and set reserves based on industry data.

About MCG

MCG, part of the Hearst Health network, helps healthcare organizations implement informed care strategies that proactively and efficiently move people toward health. MCG’s transparent assessment of the latest research and scholarly articles, along with our own data analysis, gives patients, providers, and payers the vetted information they need to feel confident in every care decision, in every moment. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.

Share article on social media or email: